The Sweetch app, now in clinical trials at Johns Hopkins Medical Center in Maryland, predicts personal diabetes risk and encourages long-term behavioral change to prevent diabetes. Read more on Israel21c...
Read MoreFrom a security perspective, the ultimate user experience involves both fraud protection and enabling legitimate users as unobtrusively as possible, BioCatch vice president Frances Zelazny said. Read more on Bankless Times...
Read MoreIron Dome developer nabs investment from New Zealand See OurCrowd’s Andy Kaye on i24 News...
Read MoreInnoviz Technologies, a leading provider of LiDAR sensing solutions, announced today that is has won the CES 2018 Innovation Awards Honoree recognition in the Vehicle Intelligence and Self-Driving Technology category for its groundbreaking InnovizPro™ High Definition Solid State LiDAR. Read more on PR Newswire...
Read MoreBased in Petah Tikva, DreaMed has two products: Advisor decision-support technology to optimize and fine-tune patient-specific insulin treatment plans (FDA and CE approval pending); and Glucositter, the first artificial pancreas system to receive the CE Mark for sales in Europe. Read more on Israel21c...
Read More
